RXRX - CIK 0001601830
RECURSION PHARMACEUTICALS, INC. has filed 908 documents with the SEC between 2014 and 2026. The most frequent type is insider trade (450 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2025-09-17 | 2025-09-15 |
| Insider trade | 4 | 2025-09-12 | 2025-09-10 |
| Insider sale notice | 144 | 2025-09-10 | - |
| Major company event (amended) | 8-K/A | 2025-08-29 | 2025-07-08 |
| 424B7 | - | 2025-08-29 | - |
| Insider trade | 4 | 2025-08-28 | 2025-08-26 |
| Insider sale notice | 144 | 2025-08-26 | - |
| Insider trade | 4 | 2025-08-19 | 2025-08-15 |
| Insider trade | 4 | 2025-08-19 | 2025-08-15 |
| Insider trade | 4 | 2025-08-19 | 2025-08-15 |
| Insider sale notice | 144 | 2025-08-18 | - |
| Insider trade | 4 | 2025-08-13 | 2025-08-11 |
| Insider sale notice | 144 | 2025-08-11 | - |
| Quarterly report | 10-Q | 2025-08-05 | 2025-06-30 |
| Major company event | 8-K | 2025-08-05 | 2025-08-05 |
| Major company event | 8-K | 2025-07-08 | 2025-07-08 |
| 424B7 | - | 2025-07-08 | - |
| Insider trade | 4 | 2025-07-03 | 2025-07-01 |
| Insider trade | 4 | 2025-07-03 | 2025-07-01 |
| Insider trade | 4 | 2025-06-23 | 2025-06-18 |
| Insider trade | 4 | 2025-06-23 | 2025-06-18 |
| Insider trade | 4 | 2025-06-23 | 2025-06-18 |
| Insider trade | 4 | 2025-06-23 | 2025-06-18 |
| Insider trade | 4 | 2025-06-23 | 2025-06-18 |
| Insider trade | 4 | 2025-06-23 | 2025-06-18 |
| Insider trade | 4 | 2025-06-23 | 2025-06-18 |
| Insider trade | 4 | 2025-06-18 | 2025-06-16 |
| Major company event | 8-K | 2025-06-18 | 2025-06-18 |
| Major company event | 8-K | 2025-06-10 | 2025-06-10 |
| Insider trade | 4 | 2025-05-19 | 2025-05-15 |
| Insider trade | 4 | 2025-05-19 | 2025-05-15 |
| Insider trade | 4 | 2025-05-19 | 2025-05-15 |
| Major company event | 8-K | 2025-05-09 | 2025-05-09 |
| 424B7 | - | 2025-05-09 | - |
| Employee stock plan | S-8 | 2025-05-05 | - |
| Quarterly report | 10-Q | 2025-05-05 | 2025-03-31 |
| Major company event | 8-K | 2025-05-05 | 2025-05-05 |
| Annual report to shareholders | ARS | 2025-04-28 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-28 | - |
| Proxy statement | DEF 14A | 2025-04-28 | 2025-04-28 |
| Insider trade | 4 | 2025-04-03 | 2025-04-01 |
| Insider trade | 4 | 2025-04-03 | 2025-04-01 |
| Insider trade | 4 | 2025-04-03 | 2025-04-01 |
| Insider trade | 4 | 2025-03-28 | 2025-03-27 |
| Insider sale notice | 144 | 2025-03-27 | - |
| Insider trade | 4 | 2025-03-19 | 2025-03-17 |
| Insider trade | 4 | 2025-03-19 | 2025-03-17 |
| Insider trade | 4 | 2025-03-19 | 2025-03-17 |
| New insider ownership | 3 | 2025-03-19 | 2025-03-15 |
| New insider ownership | 3 | 2025-03-19 | 2025-03-15 |